Ledger.Open graph →

SEC Form D · filed March 29, 2021

NEURONA THERAPEUTICS, INC

Offering

$40.0M

Sold

$28.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Stephen R. Hauser · South San Francisco, CADirector Leo R. Guthart · South San Francisco, CADirector Erica Whittaker · South San Francisco, CADirector Tim Kutzkey · South San Francisco, CADirector Robert Tjian · South San Francisco, CADirector Cory Nicholas · South San Francisco, CAExec · Director Arnold R. Kriegstein · South San Francisco, CADirector Catherine Sohn · South San Francisco, CADirector Benjamin Carter · South San Francisco, CADirector Alan Badey · New York, NYExec · Director Wendy A. Kei · Toronto, Ontario, CanadaDirector Joel Cooperman · New York, NYDirector Michael Burwell · New York, NYDirector William R. Woo · New York, NYDirector Alger A. St-Jean · Toronto, Ontario, CanadaDirector Michael Weisz · New York, NYDirector Dhivya Venkat · London, United KingdomDirector Barbara M. Sullivan · Lake Forest, ILDirector Sabrina Hahn · Alpine, NJDirector Minyoung Sohn · Denver, COExec · Director Bobby Ocampo · Solana Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗